Search research articles
Contact Us
Filters
Showing results (61-70 of 687) with videos related to
Page
of 69
Sort By:
European Journal of Heart Failure
|
June 10, 2024
When chronic kidney disease (CKD) intersects with heart failure: Insights and implications of the identification of KDIGO-defined CKD in 1.4 million U.S. Veterans with heart failure
Bertram Pitt, Patrick Rossignol
The American Journal of Cardiology
|
May 12, 2009
A history of systemic hypertension and incident heart failure hospitalization in patients with acute myocardial infarction and left ventricular systolic dysfunction
Ali Ahmed, Bertram Pitt
Heart Failure Clinics
|
July 28, 2009
Biomarkers of extracellular matrix turnover
Faiez Zannad, Bertram Pitt
Drugs
|
March 28, 2007
Drospirenone for oral contraception and hormone replacement therapy: are its cardiovascular risks and benefits the same as other progestogens?
Apurva Motivala, Bertram Pitt
Therapeutic Advances in Chronic Disease
|
December 20, 2012
Eplerenone: is it time to add this drug to current heart failure therapy?
Bertram Pitt, Faiez Zannad
European Journal of Heart Failure
|
December 19, 2018
Future large-scale clinical trials in cardiovascular medicine: challenges and uncertainties
Milton Packer, Bertram Pitt
Journal of the American College of Cardiology
|
November 5, 2013
Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysis
Bertram Pitt, Patrick Rossignol
Expert Opinion on Pharmacotherapy
|
May 17, 2016
Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer
Murray Epstein, Bertram Pitt
Expert Opinion on Drug Safety
|
March 10, 2016
The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure
Bertram Pitt, Patrick Rossignol
JAMA Internal Medicine
|
May 26, 2018
Mineralocorticoid Receptor Antagonists in ST-Segment Elevation Myocardial Infarction
Bertram Pitt, Faiez Zannad
Page
of 69
Search research articles
Search
Showing results (61-70 of 687) with videos related to
Sort By:
Page
of 69
European Journal of Heart Failure
|
June 10, 2024
When chronic kidney disease (CKD) intersects with heart failure: Insights and implications of the identification of KDIGO-defined CKD in 1.4 million U.S. Veterans with heart failure
Bertram Pitt, Patrick Rossignol
The American Journal of Cardiology
|
May 12, 2009
A history of systemic hypertension and incident heart failure hospitalization in patients with acute myocardial infarction and left ventricular systolic dysfunction
Ali Ahmed, Bertram Pitt
Heart Failure Clinics
|
July 28, 2009
Biomarkers of extracellular matrix turnover
Faiez Zannad, Bertram Pitt
Drugs
|
March 28, 2007
Drospirenone for oral contraception and hormone replacement therapy: are its cardiovascular risks and benefits the same as other progestogens?
Apurva Motivala, Bertram Pitt
Therapeutic Advances in Chronic Disease
|
December 20, 2012
Eplerenone: is it time to add this drug to current heart failure therapy?
Bertram Pitt, Faiez Zannad
European Journal of Heart Failure
|
December 19, 2018
Future large-scale clinical trials in cardiovascular medicine: challenges and uncertainties
Milton Packer, Bertram Pitt
Journal of the American College of Cardiology
|
November 5, 2013
Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysis
Bertram Pitt, Patrick Rossignol
Expert Opinion on Pharmacotherapy
|
May 17, 2016
Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer
Murray Epstein, Bertram Pitt
Expert Opinion on Drug Safety
|
March 10, 2016
The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure
Bertram Pitt, Patrick Rossignol
JAMA Internal Medicine
|
May 26, 2018
Mineralocorticoid Receptor Antagonists in ST-Segment Elevation Myocardial Infarction
Bertram Pitt, Faiez Zannad
Page
of 69